Drug Profile
LXR 0151
Alternative Names: LexirinLatest Information Update: 03 May 2000
Price :
$50
*
At a glance
- Originator LXR Biotechnology
- Class Antidiarrhoeals
- Mechanism of Action Apoptosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 03 May 2000 Discontinued-I for Diarrhoea in USA (PO)
- 12 Jun 1997 Suspended-I for Diarrhoea in USA (PO)
- 06 Aug 1996 New profile